Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-19

FDA Approved: INVEGA — Original Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Janssen's INVEGA (paliperidone) under an original New Drug Application for the treatment of schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA (PALIPERIDONE)

Snippet

ORIG AP for INVEGA (PALIPERIDONE)